Amirali Talasaz

This inventor holds 88 USPTO granted patents and 30 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Cancer Detection Technologies (CPC class C12Q1-6869). Top assignee: Guardant Health, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amirali Talasaz. Retrieved from https://idiyas.com/inventor/amirali-talasaz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 88 (Patent Applications = 30)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 1.8

ph-index = 17

Forward Citations = 624(Granted Patents)

Forward Citations (Not Self Cited) = 179(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Company Filing History:

88 out of 150

Guardant Health, Inc.

patents

Years Active: 2019-2026

Loading Chart...

Areas of Expertise:

Cancer Detection

Genetic Variants

Nucleic Acid Analysis

Rare Mutations

Copy Number Variation

Early Detection

Cancer Diagnostics

EGFR Mutations

KRAS Alterations

MET Gene

88 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12744128 - Predictive model for determining changes in molecular state (2026-09-22),

2. 12735751 - Systems and methods to detect rare mutations and copy number variation (2026-09-15),

3. 12706179 - Population based treatment recommender using cell free DNA (2026-08-11),

4. 12706178 - Population based treatment recommender using cell free dna (2026-08-11),

5. 12692554 - Systems and methods to detect rare mutations and copy number variation (2026-07-28),

6. 12662697 - Systems and methods to detect rare mutations and copy number variation (2026-06-23),

7. 12624400 - Systems and methods to detect rare mutations and copy number variation (2026-05-12),

8. 12606874 - Systems and methods to detect rare mutations and copy number variation (2026-04-21),

9. 12597524 - Cancer evolution detection and diagnostic (2026-04-07),

10. 12571055 - Methods for early detection of cancer (2026-03-10),

11. 12571053 - Methods for early detection of cancer (2026-03-10),

12. 12565674 - METHODS AND SYSTEMS FOR ANALYZING NUCLEIC ACID MOLECULES (2026-03-03),

13. 12435368 - Methods and systems for detecting genetic variants (2025-10-07),

14. 12428670 - Methods and systems for analyzing nucleic acid molecules (2025-09-30),

15. 12359245 - Methods and systems for analyzing nucleic acid molecules (2025-07-15),

Title: Innovator Spotlight: Amirali Talasaz Revolutionizing Genetic Detection in Atherton, CA

Introduction:

Amirali Talasaz, a visionary inventor based in Atherton, CA, is making waves in the field of genetic detection with his groundbreaking innovations. With an impressive portfolio of 51 patents, Talasaz is at the forefront of developing systems and methods for detecting rare mutations and copy number variations in cell-free polynucleotides.

Latest Patents:

Talasaz's latest patents showcase his pioneering work in genetic diagnostics. The systems and methods he has developed enable the detection of rare mutations and copy number variations in cell-free polynucleotides extracted from bodily fluids. By leveraging advanced sequencing techniques and bioinformatics tools, these innovations open new possibilities in genetic profiling for various diseases.

Career Highlights:

Throughout his career, Talasaz has demonstrated a deep commitment to advancing precision medicine. He has made significant contributions to companies like Guardant Health, Inc., where his expertise has been instrumental in driving innovation in genetic testing technologies. His relentless pursuit of excellence has earned him recognition as a leading figure in the field of genetic diagnostics.

Collaborations:

Talasaz has collaborated with esteemed professionals in the industry, including Stefanie Ann Ward Mortimer and Helmy A Eltoukhy. Together, they have pushed the boundaries of genetic detection and paved the way for transformative advancements in healthcare.

Conclusion:

In conclusion, Amirali Talasaz's passion for innovation and his relentless pursuit of excellence have positioned him as a trailblazer in the field of genetic diagnostics. His remarkable contributions to the development of systems and methods for detecting rare mutations and copy number variations reflect his unwavering commitment to revolutionizing genetic profiling. Talasaz's work not only transforms the landscape of precision medicine but also offers hope for improved diagnostics and treatments in the future.

Profile summary based on public USPTO records.